Biocon raises stake in Biocon Biologics to 98% after completing $200 million share buyout
Biotech firm Biocon Ltd on Tuesday (January 21) said it has completed the acquisition of the remaining equity shares of its unlisted material subsidiary, Biocon Biologics Ltd (BBL), from...
